When to Switch Medications or Adjust Your Treatment Plan If palpitations persist despite hydration, slow dose increases, and lifestyle changes after 34 weeks, your provider may recommend a lower microdose, a pause in treatment, or a switch to a different GLP-1 compound
Both compound classes are contraindicated in active malignancy by clinical convention, given IGF-1's mitogenic properties
To get around this, the tablet includes an absorption enhancer called SNAC (sodium N-(8-(2-hydroxybenzoyl)amino)caprylate), which protects the semaglutide and helps a small, steady amount pass through the stomach lining
doi: 10.1016/j.jddst.2016.06.007 176
Daily dosing vs three times weekly dosing The question of whether you can reduce from daily to three times per week comes up frequently with sublingual GLP-1 drops